A Phase I Prospective, Randomized, Double-blind, Placebo-controlled Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN 400 and Low Dose Aspirin.

Trial Profile

A Phase I Prospective, Randomized, Double-blind, Placebo-controlled Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN 400 and Low Dose Aspirin.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2011

At a glance

  • Drugs Aspirin; Esomeprazole/naproxen
  • Indications Ankylosing spondylitis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis; Thrombosis
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 06 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Dec 2010 Last checked against ClinicalTrials.gov record.
    • 01 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top